Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |